__timestamp | BioMarin Pharmaceutical Inc. | MiMedx Group, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 621276000 | 105558000 |
Thursday, January 1, 2015 | 737887000 | 167094000 |
Friday, January 1, 2016 | 907234000 | 212608000 |
Sunday, January 1, 2017 | 1071860000 | 285920000 |
Monday, January 1, 2018 | 1175948000 | 322725000 |
Tuesday, January 1, 2019 | 1344582000 | 256174000 |
Wednesday, January 1, 2020 | 1336183000 | 208904000 |
Friday, January 1, 2021 | 1375760000 | 215332000 |
Saturday, January 1, 2022 | 1612370000 | 219525000 |
Sunday, January 1, 2023 | 1842161000 | 266843000 |
Monday, January 1, 2024 | 2273680000 |
Unleashing the power of data
In the competitive world of biotechnology, financial performance is a key indicator of a company's success. Over the past decade, BioMarin Pharmaceutical Inc. and MiMedx Group, Inc. have showcased contrasting trajectories in their gross profit margins. From 2014 to 2023, BioMarin's gross profit surged by nearly 200%, peaking at approximately $1.84 billion in 2023. This growth reflects BioMarin's strategic advancements and robust product pipeline.
Conversely, MiMedx Group, Inc. experienced a more modest increase, with gross profits rising by about 150% over the same period, reaching around $267 million in 2023. Despite the slower growth, MiMedx's focus on regenerative medicine continues to hold promise. This financial snapshot underscores the dynamic nature of the biotech industry, where innovation and strategic positioning can lead to significant financial outcomes.
Gross Profit Comparison: Merck & Co., Inc. and MiMedx Group, Inc. Trends
Who Generates Higher Gross Profit? Novartis AG or MiMedx Group, Inc.
Who Generates Higher Gross Profit? Pfizer Inc. or BioMarin Pharmaceutical Inc.
Key Insights on Gross Profit: Alnylam Pharmaceuticals, Inc. vs MiMedx Group, Inc.
Gross Profit Comparison: United Therapeutics Corporation and BioMarin Pharmaceutical Inc. Trends
Who Generates Higher Gross Profit? Dr. Reddy's Laboratories Limited or MiMedx Group, Inc.
Gross Profit Analysis: Comparing Bio-Techne Corporation and MiMedx Group, Inc.
Who Generates Higher Gross Profit? BioMarin Pharmaceutical Inc. or Halozyme Therapeutics, Inc.
Key Insights on Gross Profit: BioMarin Pharmaceutical Inc. vs HUTCHMED (China) Limited
BioMarin Pharmaceutical Inc. and MiMedx Group, Inc.: A Comprehensive Revenue Analysis
BioMarin Pharmaceutical Inc. vs Evotec SE: A Gross Profit Performance Breakdown
Gross Profit Comparison: Bausch Health Companies Inc. and MiMedx Group, Inc. Trends